28th June 2010
24sure performance confirmed by results of two centre clinical study
5th November 2009
BlueGnome ranked the fastest growing biotechnology company in Cambridgeshire
8th September 2009
First baby born using BlueGnome's 24sure single cell screening technology
1st July 2009
BlueGnome announces SurePlex DNA Amplification System
28th June 2009
ESHRE launches international study of polar body screening using BlueGnome's 24sure platform
29th May 2009
BlueGnome launches "Upgrade me" plan to help laboratories scale up arrayCGH
3rd May 2009
BlueGnome releases BlueFuse Multiv2; a comprehensive arrayCGH database solution
9th October 2008
BlueGnome launches 24sure microarray for single cell aneuploidy screening
1st September 2008
BlueGnome completes initial validation of new ultra robust array format
1st June 2008
BlueGnome launches the world's largest FISH library
25th October 2007
BlueGnome announces first sales of CytoChip in the United States
4th September 2007
MGZ Munich completes validation of higher resolution v2 CytoChip
12th June 2007
Roswell Park License to BlueGnome, Ltd, Supports Institute Research and Patient Care
30th April 2007
Dutch medical centre achieves accreditation for clinical use of microarrays
5th March 2007
Results of clinical arrayCGH are made easier to interpret and report
9th June 2006
Tecan and BlueGnome collaborate to improve repeatability of clinical arrayCGH
7th June 2006
BlueGnome hosts Biomarkers Technology Update Seminar
14th February 2006
BlueGnome announces availability of CytoChip for clinical diagnostic applications
9th January 2006
BlueGnome launches BlueFuse for Biomarkers
26th October 2005
ancer research given boost by new software
7th May 2005
BlueGnome launches ground-breaking genetics software
7th April 2005
New BlueFuse offers automated arrayCGH mapping
22nd September 2004
Pushing back the boundaries in food research
21st April 2004
BlueFuse to improve objectivity and throughput at world leading pathology department
9th January 2004
Safer and more effective clinical trials come a step closer with Wellcome award